Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Philip Crawford Amrein, M.D.

Concepts (420)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Philip Amrein's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Philip Amrein has written about over time.
Aminoacridines, 5 publications between 1982 and 1984, average publication date December 1983. Carcinoma, Squamous Cell, 9 publications between 1983 and 2005, average publication date December 1994. Head and Neck Neoplasms, 9 publications between 1983 and 2005, average publication date December 1994. Paranasal Sinus Neoplasms, 2 publications between 1997 and 2002, average publication date September 1999. Leukemia, Myeloid, 7 publications between 1997 and 2019, average publication date July 2005. Antineoplastic Combined Chemotherapy Protocols, 31 publications between 1983 and 2022, average publication date October 2005. Remission Induction, 16 publications between 1990 and 2022, average publication date March 2009. Thiazoles, 2 publications between 2011 and 2011, average publication date March 2011. Maximum Tolerated Dose, 8 publications between 2003 and 2019, average publication date May 2011. Leukemia, Myeloid, Acute, 30 publications between 1990 and 2023, average publication date October 2012. fms-Like Tyrosine Kinase 3, 5 publications between 2010 and 2017, average publication date November 2012. Cytarabine, 12 publications between 2000 and 2019, average publication date June 2013. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 6 publications between 1992 and 2022, average publication date July 2014. Glutarates, 3 publications between 2012 and 2018, average publication date April 2015. Pyrimidines, 5 publications between 2011 and 2020, average publication date November 2015. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 5 publications between 2011 and 2021, average publication date March 2017. Azepines, 2 publications between 2016 and 2019, average publication date June 2018. Leukemia, Myeloid, Chronic-Phase, 1 publications between 2021 and 2021, average publication date November 2021.

To see the data from this visualization as text, click here.
Amrein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (420)
Explore
_
Co-Authors (102)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.